CoChat

A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome

Open access
Shele, Grei, Genkil, Jessica, Speelman, Diana · 2020 · Journal of Functional Morphology and Kinesiology
Cited by 115

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder that is characterized by menstrual irregularity and elevated serum androgens, and is often accompanied by insulin resistance. The etiology of PCOS is unknown. Lifestyle interventions and weight loss, where appropriate, remain first-line treatments for women with PCOS. Regular physical activity is recommended for women with PCOS to maintain a healthy weight and cardiovascular fitness. Purpose: To review the evidence for the impact of various exercise interventions on hormone levels in women with PCOS. Methods: A systematic review of original studies indexed in PubMed that utilized an exercise intervention in women with PCOS and reported hormone values pre- and post-intervention. Studies in which the effects of the exercise intervention could be determined were included. Results: Vigorous aerobic exercise improves insulin measures in women with PCOS. Resistance or strength training may improve androgen levels, though additional studies are warranted. Studies with yoga are limited but suggest improvements in androgens. Limited information is available on the impact of exercise on adipokines and anti-Müllerian hormone, warranting further investigation. Conclusions: Recommended guidelines for women with PCOS include vigorous aerobic exercise and resistance training to improve measures of insulin sensitivity and androgen levels.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jfmk5020035

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 100

  1. Lujan, 2008, Diagnostic Criteria for Polycystic Ovary Syndrome: Pitfalls and Controversies, J. Obstet. Gynaecol. Can., 30, 671, 10.1016/S1701-2163(16)32915-2 · DOI · Paper page
  2. Raj, 1978, Diagnostic value of androgen measurements in polycystic ovary syndrome, Obstet. Gynecol., 52, 169
  3. Stuckey, 2014, Clustering of metabolic and cardiovascular risk factors in the polycystic ovary syndrome: A principal component analysis, Metabolism, 63, 1071, 10.1016/j.metabol.2014.05.004 · DOI
  4. Talbott, 2000, Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women, Arter. Thromb. Vasc. Boil., 20, 2414, 10.1161/01.ATV.20.11.2414 · DOI · Paper page
  5. Boulman, 2004, Increased C-Reactive Protein Levels in the Polycystic Ovary Syndrome: A Marker of Cardiovascular Disease, J. Clin. Endocrinol. Metab., 89, 2160, 10.1210/jc.2003-031096 · DOI · Paper page
  6. Tarkun, 2004, Endothelial Dysfunction in Young Women with Polycystic Ovary Syndrome: Relationship with Insulin Resistance and Low-Grade Chronic Inflammation, J. Clin. Endocrinol. Metab., 89, 5592, 10.1210/jc.2004-0751 · DOI · Paper page
  7. Teede, 2006, Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS, Endocrine, 30, 45, 10.1385/ENDO:30:1:45 · DOI
  8. Motalebi, 2014, Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis, Hepat. Mon., 14, 23235
  9. Weiner, 2004, Androgens and mood dysfunction in women: Comparison of women with polycystic ovarian syndrome to healthy controls, Psychosom. Med., 66, 356
  10. Deeks, 2010, Anxiety and depression in polycystic ovary syndrome: A comprehensive investigation, Fertil. Steril., 93, 2421, 10.1016/j.fertnstert.2009.09.018 · DOI · Paper page
  11. Jedel, 2009, Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index, Hum. Reprod., 25, 450, 10.1093/humrep/dep384 · DOI · Paper page
  12. Rassi, 2010, Prevalence of psychiatric disorders in patients with polycystic ovary syndrome, Compr. Psychiatry, 51, 599, 10.1016/j.comppsych.2010.02.009 · DOI
  13. Barry, 2011, Testosterone and mood dysfunction in women with polycystic ovarian syndrome compared to subfertile controls, J. Psychosom. Obstet. Gynecol., 32, 104, 10.3109/0167482X.2011.568129 · DOI
  14. Livadas, 2011, Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome, Clin. Endocrinol., 75, 698, 10.1111/j.1365-2265.2011.04122.x · DOI · Paper page
  15. Dokras, 2012, Mood and anxiety disorders in women with PCOS, Steroids, 77, 338, 10.1016/j.steroids.2011.12.008 · DOI
  16. Lenarcik, 2012, Psychiatric disorders related to polycystic ovary syndrome, Endokrynol. Polska, 63, 488
  17. Albayrak, 2013, Level of anxiety, depression, self-esteem, social anxiety, and quality of life among the women with polycystic ovary syndrome, Sci. World J., 2013, 851815, 10.1155/2013/851815 · DOI
  18. Mahajan, 1988, Steroidogenesis in Human Polycystic Ovary, Endocrinol. Metab. Clin. N. Am., 17, 751, 10.1016/S0889-8529(18)30408-0 · DOI
  19. Barnes, 1998, The pathogenesis of polycystic ovary syndrome: Lessons from ovarian stimulation studies, J. Endocrinol. Investig., 21, 567, 10.1007/BF03350782 · DOI
  20. Barbieri, 1986, Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism, J. Clin. Endocrinol. Metab., 62, 904, 10.1210/jcem-62-5-904 · DOI · Paper page
  21. Nestler, 1997, Insulin regulation of human ovarian androgens, Hum. Reprod., 12, 53, 10.1093/humrep/12.suppl_1.53 · DOI · Paper page
  22. Nestler, 1997, Role of Hyperinsulinemia in the Pathogenesis of the Polycystic Ovary Syndrome, and Its Clinical Implications, Semin. Reprod. Med., 15, 111, 10.1055/s-2007-1016294 · DOI · Paper page
  23. Dunaif, 1992, Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome, Diabetes, 41, 1257, 10.2337/diab.41.10.1257 · DOI · Paper page
  24. Corbould, 2006, Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome, Diabetes, 55, 751, 10.2337/diabetes.55.03.06.db05-0453 · DOI · Paper page
  25. Book, 1999, Selective insulin resistance in the polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 84, 3110
  26. Kouli, 1999, A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile, J. Clin. Endocrinol. Metab., 84, 4006, 10.1210/jcem.84.11.6148 · DOI · Paper page
  27. Grulet, 1993, Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome, Clin. Endocrinol., 38, 621, 10.1111/j.1365-2265.1993.tb02144.x · DOI · Paper page
  28. Dunaif, 1997, Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis, Endocr. Rev., 18, 774
  29. Artini, 2010, Best methods for identification and treatment of PCOS, Minerva Ginecol., 62, 33
  30. Costello, 2012, Evidence-Based Lifestyle and Pharmacological Management of Infertility in Women with Polycystic Ovary Syndrome, Womens Health, 8, 277
  31. Bates, 2012, Longterm management of Polycystic Ovarian Syndrome (PCOS), Mol. Cell. Endocrinol., 373, 91, 10.1016/j.mce.2012.10.029 · DOI · Paper page
  32. Carmina, 2012, Obesity, Adipokines and Metabolic Syndrome in Polycystic Ovary Syndrome, Front. Horm. Res., 40, 40, 10.1159/000341840 · DOI
  33. Mirza, 2014, Association between circulating adiponectin levels and polycystic ovarian syndrome, J. Ovarian Res., 7, 18, 10.1186/1757-2215-7-18 · DOI
  34. Sarray, 2015, Validity of adiponectin-to-leptin and adiponectin-to-resistin ratios as predictors of polycystic ovary syndrome, Fertil. Steril., 104, 460, 10.1016/j.fertnstert.2015.05.007 · DOI
  35. Noroozzadeh, 2017, The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines, J. Endocrinol. Investig., 40, 859, 10.1007/s40618-017-0650-x · DOI
  36. Holte, 1994, The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women, Clin. Endocrinol., 41, 473, 10.1111/j.1365-2265.1994.tb02578.x · DOI · Paper page
  37. Marshall, 1999, NEUROENDOCRINE ASPECTS OF POLYCYSTIC OVARY SYNDROME, Endocrinol. Metab. Clin. N. Am., 28, 295, 10.1016/S0889-8529(05)70071-2 · DOI
  38. Li, 2020, Age-specific reference ranges of serum anti-müllerian hormone in healthy women and its application in diagnosis of polycystic ovary syndrome: A population study, BJOG Int. J. Obstet. Gynaecol., 127, 720, 10.1111/1471-0528.16147 · DOI
  39. Jacob, 2016, Anti-Müllerian hormone reflects the severity of polycystic ovary syndrome, Clin. Endocrinol., 86, 395, 10.1111/cen.13269 · DOI
  40. Laven, 2017, Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: Redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis, Hum. Reprod., 32, 1723, 10.1093/humrep/dex226 · DOI
  41. Matsuzaki, 2017, Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome, Endocr. J., 64, 531, 10.1507/endocrj.EJ16-0501 · DOI
  42. Sathyapalan, 2018, Anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome, Clin. Endocrinol., 88, 258, 10.1111/cen.13517 · DOI
  43. Ahmed, N., Batarfi, A.A., Bajouh, O.S., and Bakhashab, S. (2019). Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms. Diagnostics, 9. · DOI
  44. Karkanaki, 2009, Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: Study in normal weight, normoinsulinemic patients, Fertil. Steril., 92, 2078, 10.1016/j.fertnstert.2009.06.034 · DOI
  45. Niafar, 2015, Adiponectin as serum biomarker of insulin resistance in patients with polycystic ovarian syndrome, Gynecol. Endocrinol., 31, 1, 10.3109/09513590.2015.1008445 · DOI
  46. Chan, 2007, Increased plasma visfatin concentrations in women with polycystic ovary syndrome, Fertil. Steril., 88, 401, 10.1016/j.fertnstert.2006.11.120 · DOI
  47. Kowalska, 2007, Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome, Hum. Reprod., 22, 1824, 10.1093/humrep/dem118 · DOI · Paper page
  48. Panidis, 2008, Plasma visfatin levels in normal weight women with polycystic ovary syndrome, Eur. J. Intern. Med., 19, 406, 10.1016/j.ejim.2007.05.014 · DOI
  49. Gen, 2009, Plasma visfatin level in lean women with PCOS: Relation to proinflammatory markers and insulin resistance, Gynecol. Endocrinol., 25, 241, 10.1080/09513590802585613 · DOI
  50. Tarkun, 2010, Plasma visfatin level in women with polycystic ovary syndrome, Gynecol. Endocrinol., 27, 475
  51. Farshchian, 2014, Visfatin and resistin serum levels in normal-weight and obese women with polycystic ovary syndrome, Int. J. Endocrinol. Metab., 12, 15503, 10.5812/ijem.15503 · DOI
  52. Lewandowski, 2005, Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: A significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices, Mol. Genet. Metab., 85, 61, 10.1016/j.ymgme.2004.12.014 · DOI
  53. Seow, 2004, Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance, Hum. Reprod., 19, 48, 10.1093/humrep/deh010 · DOI
  54. Munir, 2005, Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: Relevance to polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 90, 4852, 10.1210/jc.2004-2152 · DOI · Paper page
  55. Zheng, 2016, Leptin Levels in Women With Polycystic Ovary Syndrome: A Systematic Review and a Meta-Analysis, Reprod. Sci., 24, 656, 10.1177/1933719116670265 · DOI
  56. Mantzoros, 1997, Leptin concentrations in the polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 82, 1687
  57. Baldani, 2019, Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality, Gynecol. Endocrinol., 35, 401, 10.1080/09513590.2018.1534096 · DOI
  58. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2012). Consensus on women’s health aspects of polycystic ovary syndrome (PCOS). Hum. Reprod., 27, 14–24. · DOI · Paper page
  59. Hoeger, 2008, Exercise Therapy in Polycystic Ovary Syndrome, Semin. Reprod. Med., 26, 93, 10.1055/s-2007-992929 · DOI
  60. Giallauria, 2008, Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS), Clin. Endocrinol., 69, 792, 10.1111/j.1365-2265.2008.03305.x · DOI
  61. Orio, 2008, Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women, Clin. Endocrinol., 68, 976, 10.1111/j.1365-2265.2007.03117.x · DOI
  62. Orio, 2016, Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: A randomized controlled trial, Clin. Endocrinol., 85, 764, 10.1111/cen.13112 · DOI · Paper page
  63. Lopes, 2018, Comparison of the Effect of Intermittent and Continuous Aerobic Physical Training on Sexual Function of Women With Polycystic Ovary Syndrome: Randomized Controlled Trial, J. Sex. Med., 15, 1609, 10.1016/j.jsxm.2018.09.002 · DOI · Paper page
  64. Ribeiro, V.B., Lopes, I.P., Dos Reis, R.M., Silva, R.C., Mendes, M.C., Melo, A.S., de Souza, H.C.D., Ferriani, R.A., Kogure, G.S., and Lara, L.A.D.S. (2019). Continuous versus intermittent aerobic exercise in the improvement of quality of life for women with polycystic ovary syndrome: A randomized controlled trial. J. Health Psychol. · DOI
  65. Ribeiro, V.B., Kogure, G.S., Lopes, I.P., Silva, R.C., Pedroso, D.C.C., de Melo, A.S., de Souza, H.C.D., Ferriani, R.A., Miranda Furtado, C.L., and Dos Reis, R.M. (2020). Effects of continuous and intermittent aerobic physical training on hormonal and metabolic profile, and body composition in women with polycystic ovary syndrome: A randomized controlled trial. Clin. Endocrinol. · DOI
  66. Brown, 2009, Effects of exercise on lipoprotein particles in women with polycystic ovary syndrome, Med. Sci. Sports Exerc., 41, 497, 10.1249/MSS.0b013e31818c6c0c · DOI · Paper page
  67. Baghaei, 2012, Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: Secondary analyses of a randomized controlled trial, Fertil. Steril., 97, 501, 10.1016/j.fertnstert.2011.11.010 · DOI
  68. Leonhardt, 2015, Serum anti-Müllerian hormone and ovarian morphology assessed by magnetic resonance imaging in response to acupuncture and exercise in women with polycystic ovary syndrome: Secondary analyses of a randomized controlled trial, Acta Obstet. Gynecol. Scand., 94, 279, 10.1111/aogs.12571 · DOI
  69. Jedel, 2011, Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: A randomized controlled trial, Am. J. Physiol. Metab., 300, E37
  70. Moran, 2011, Exercise decreases anti-müllerian hormone in anovulatory overweight women with polycystic ovary syndrome: A pilot study, Horm. Metab. Res., 43, 977, 10.1055/s-0031-1291208 · DOI · Paper page
  71. Stepto, 2020, Exercise and insulin resistance in PCOS: Muscle insulin signalling and fibrosis, Endocr. Connect., 9, 346, 10.1530/EC-19-0551 · DOI
  72. Hutchison, 2012, Effect of exercise training on insulin sensitivity, mitochondria and computed tomography muscle attenuation in overweight women with and without polycystic ovary syndrome, Diabetologia, 55, 1424, 10.1007/s00125-011-2442-8 · DOI
  73. Scott, D., Teede, H.J., Rachoń, D., Harrison, C.L., Strauss, B.J., and Stepto, N.K. (2017). Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome. PLoS ONE, 12. · DOI
  74. Moro, 2009, Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 94, 2579, 10.1210/jc.2009-0051 · DOI · Paper page
  75. Redman, 2011, Aerobic exercise in women with polycystic ovary syndrome improves ovarian morphology independent of changes in body composition, Fertil. Steril., 95, 2696, 10.1016/j.fertnstert.2011.01.137 · DOI · Paper page
  76. Covington, 2014, Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise, Biochimie, 124, 27, 10.1016/j.biochi.2014.10.028 · DOI
  77. Sprung, 2013, Exercise training in polycystic ovarian syndrome enhances flow-mediated dilation in the absence of changes in fatness, Med. Sci. Sports Exerc., 45, 2234, 10.1249/MSS.0b013e31829ba9a1 · DOI
  78. Sprung, 2013, Nitric oxide-mediated cutaneous microvascular function is impaired in polycystic ovary sydrome but can be improved by exercise training, J. Physiol., 591, 1475, 10.1113/jphysiol.2012.246918 · DOI
  79. Aye, 2018, Dynamic Change in Insulin Resistance Induced by Free Fatty Acids Is Unchanged Though Insulin Sensitivity Improves Following Endurance Exercise in PCOS, Front. Endocrinol., 9, 592, 10.3389/fendo.2018.00592 · DOI
  80. Halama, 2019, Metabolomics of Dynamic Changes in Insulin Resistance Before and After Exercise in PCOS, Front. Endocrinol., 10, 116, 10.3389/fendo.2019.00116 · DOI · Paper page
  81. Randeva, 2002, Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 87, 4496, 10.1210/jc.2001-012056 · DOI · Paper page
  82. Joham, 2012, Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: Impact of exercise training, Obesity, 20, 2390, 10.1038/oby.2012.135 · DOI
  83. Aktaş, H., Uzun, Y.E., Kutlu, O., Pençe, H.H., Özçelik, F., Çil, E., Irak, L., Altun, Ö., Özcan, M., and Özsoy, N. (2019). The effects of high intensity-interval training on vaspin, adiponectin and leptin levels in women with polycystic ovary syndrome. Arch. Physiol. Biochem., 1–6. · DOI
  84. Nybacka, 2013, Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: Secondary analysis of a randomized controlled trial, Fertil. Steril., 100, 1096, 10.1016/j.fertnstert.2013.06.030 · DOI
  85. Legro, 2012, Obesity and PCOS: Implications for diagnosis and treatment, Semin. Reprod. Med., 30, 496, 10.1055/s-0032-1328878 · DOI · Paper page
  86. Ramos, 2015, A Nonrandomized Trial of Progressive Resistance Training Intervention in Women With Polycystic Ovary Syndrome and Its Implications in Telomere Content, Reprod. Sci., 23, 644
  87. Kogure, 2018, Hyperandrogenism Enhances Muscle Strength After Progressive Resistance Training, Independent of Body Composition, in Women With Polycystic Ovary Syndrome, J. Strength Cond. Res., 32, 2642, 10.1519/JSC.0000000000002714 · DOI
  88. Kogure, 2019, Effects of Progressive Resistance Training on Obesity Indices in Polycystic Ovary Syndrome and the Relationship With Telomere Length, J. Phys. Act. Health, 16, 601, 10.1123/jpah.2018-0256 · DOI
  89. Ramos, 2016, Quality of Life in Women with Polycystic Ovary Syndrome after a Program of Resistance Exercise Training, Rev. Bras. Ginecol. Obstet., 38, 340, 10.1055/s-0036-1585457 · DOI
  90. Nidhi, 2012, Effect of a yoga program on glucose metabolism and blood lipid levels in adolescent girls with polycystic ovary syndrome, Int. J. Gynaecol. Obstet., 118, 37, 10.1016/j.ijgo.2012.01.027 · DOI
  91. Patel, 2020, Regular Mindful Yoga Practice as a Method to Improve Androgen Levels in Women With Polycystic Ovary Syndrome: A Randomized, Controlled Trial, J. Am. Osteopath. Assoc., 120, 323
  92. Dantas, 2015, GLUT4 translocation is not impaired after acute exercise in skeletal muscle of women with obesity and polycystic ovary syndrome, Obesity, 23, 2207, 10.1002/oby.21217 · DOI
  93. Giallauria, 2008, Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome, Clin. Endocrinol., 68, 88, 10.1111/j.1365-2265.2007.03004.x · DOI · Paper page
  94. Rizk, 2007, Clinical significance of serum concentration of anti-Müllerian hormone in obese women with polycystic ovary syndrome, Reprod. Biomed. Online, 15, 495, 10.1016/S1472-6483(10)60379-3 · DOI
  95. 2011, Diet composition and physical activity in overweight and obese premenopausal women with or without polycystic ovary syndrome, Gynecol. Endocrinol., 27, 978, 10.3109/09513590.2011.579658 · DOI
  96. Moran, 2017, Weight management practices associated with PCOS and their relationships with diet and physical activity, Hum. Reprod., 32, 669
  97. Greenwood, 2016, Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure, Fertil. Steril., 105, 486, 10.1016/j.fertnstert.2015.10.020 · DOI
  98. Eleftheriadou, 2012, Exercise and sedentary habits among adolescents with PCOS, J. Pediatr. Adolesc. Gynecol., 25, 172, 10.1016/j.jpag.2011.11.009 · DOI
  99. Barr, 2011, Habitual dietary intake, eating pattern and physical activity of women with polycystic ovary syndrome, Eur. J. Clin. Nutr., 65, 1126, 10.1038/ejcn.2011.81 · DOI
  100. Cramer, 2016, A Systematic Review and Meta-Analysis Estimating the Expected Dropout Rates in Randomized Controlled Trials on Yoga Interventions, Evid. Based Complement. Altern. Med., 2016, 5859729, 10.1155/2016/5859729 · DOI · Paper page

Cited by

See all 115

Metadata

Authors
Shele, G., Genkil, J., & Speelman, D.
Venue
Journal of Functional Morphology and Kinesiology
Publisher
MDPI AG
Published
2020-05-31
Volume
5
Issue
2
Pages
35
ISSN
2411-5142 (ISSN-L)
OpenAlex
W3029051490
Cited by
115
References
41
FWCI
3.13
Type
journal article
Language
en
Open access
gold
Funders
American Osteopathic Association (181627705)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.